← Back to all trials
Completed
NCT07887594
Comparison of the Effects of Ciprofol and Propofol on Cognitive Function After Painless Gastroenteroscopy
Conditions: Neurocognitive Function
Sex: All
Ages: 18 Years – 64 Years
Healthy volunteers: Yes
Enrollment: 196
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Location: Second Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang
Summary
This randomized platform trial compared ciprofol and propofol for early neurocognitive recovery in adults undergoing painless gastrointestinal endoscopy. The primary outcome was the incidence of delayed neurocognitive recovery (dNCR) at PACU discharge, assessed via MoCA, DST, SMDT, STT, and Stroop tests (≥ 1 SD decline from baseline in ≥ 2 domains). Secondary outcomes included PACU stay duration, total drug dosage, and adverse events (hypoxemia, hypotension, bradycardia, body movement). Assessments were performed at baseline and before PACU discharge (Modified Aldrete ≥ 9).
Eligibility Criteria
Inclusion Criteria:
* ASA physical status I, II, or III (concurrent diseases stable for ≥ 3 months with documented optimization)
* Scheduled for elective painless gastrointestinal endoscopy under sedation
* Provision of signed informed consent by the patient or legally authorized representative
Exclusion Criteria:
* Known psychiatric disorders, cognitive impairment, or inability to cooperate with preoperative evaluation
* Confirmed or suspected history of abuse or dependence on narcotic, sedative, or analgesic drugs
* Long-term alcohol abuse
* Body mass index (BMI) \> 30 kg/m²
* Severe cardiac, pulmonary, hepatic, or renal disease
* Known hypersensitivity to ciprofol, propofol, opioids, or related agents
Source: ClinicalTrials.gov (NCT07887594). StuddyBuddy aggregates publicly available trial information.